HCA Healthcare (HCA) financial statements
- FY2025 revenue
- $75.6B▲ +7.1%
- FY2025 net income
- $6.8B▲ +17.8%
- FY2025 diluted EPS
- $28.33▲ +28.8%
- FY2025 free cash flow
- $7.7B▲ +36.4%
HCA Healthcare income statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 75,600 | 70,603 | 64,968 |
| Pretax income | 9,832 | 8,523 | 7,706 |
| Net income | 6,784 | 5,760 | 5,242 |
| Diluted earnings per share | 28.33 | 22.00 | 18.97 |
HCA Healthcare balance sheet
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents | 1,040 | 1,933 | 935 |
| Total assets | 60,720 | 59,513 | 56,211 |
| Total liabilities (derived) | 63,491 | 58,958 | 55,151 |
| Total equity | -2,771 | 555 | 1,060 |
| Long-term debt | 41,603 | 38,333 | 37,169 |
HCA Healthcare cash flow statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 12,636 | 10,514 | 9,431 |
| Capital expenditure | -4,944 | -4,875 | -4,744 |
| Free cash flow (derived) | 7,692 | 5,639 | 4,687 |
| Dividends paid | -679 | -690 | -661 |
| Share repurchases | -10,067 | -6,042 | -3,811 |
Quarterly highlights
| USD millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 19,849 | 20,230 | 19,109 | 19,513 |
| Net income (derived) | 1,579 | 1,699 | 1,620 | 1,878 |
| Diluted earnings per share | 7.27 | 7.62 | 7.15 | n/a |
| Operating cash flow (derived) | 4,461 | 2,335 | 2,014 | 2,359 |
| Total assets | 63,452 | 63,250 | 61,450 | 60,720 |
HCA Healthcare major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| Thomas F. Frist, Jr. | 33.8% | 70,536,810 | 6 November 2026 |
| William R. Frist | 33.7% | 70,477,253 | 6 November 2026 |
| Patricia F. Elcan | 33.6% | 70,147,612 | 6 November 2026 |
| Thomas F. Frist III | 33.5% | 69,970,126 | 6 November 2026 |
| Frisco Holding II | 18.6% | 38,882,521 | 6 November 2026 |
HCA Healthcare 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 5 November 2026 | 8-K | Current report | Current report |
| 2 November 2026 | 8-K | Current report | Current report |
| 29 October 2026 | 10-Q | Quarterly report | Quarterly report |
| 27 October 2026 | 8-K | Current report | Current report |
| 29 July 2026 | 8-K | Current report | Current report |
| 28 July 2026 | 10-Q | Quarterly report | Quarterly report |
| 24 July 2026 | 8-K | Current report | Current report |
| 14 July 2026 | 8-K | Current report | Current report |
Common questions
What was HCA Healthcare's revenue in fiscal 2025?
HCA Healthcare reported $75.6 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 7.1% from fiscal 2024.
What was HCA Healthcare's net income in fiscal 2025?
HCA Healthcare reported net income of $6.8 billion for fiscal 2025, the year ended 31 December 2025, up 17.8% from fiscal 2024. Diluted earnings per share were $28.33.
What was HCA Healthcare's free cash flow in fiscal 2025?
HCA Healthcare had $7.7 billion in free cash flow in fiscal 2025. Operating cash flow was $12.6 billion and capital expenditure was $4.9 billion.
What were HCA Healthcare's total assets at the end of fiscal 2025?
HCA Healthcare reported total assets of $60.7 billion at the end of fiscal 2025, the year ended 31 December 2025.
How much HCA Healthcare history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
$10 of free credit every month for 12 months. No card needed.$10 of free credit a month. No card needed.